Year archive

Genor Biopharma Holdings Limited — 2021 filings

All 62 regulatory filings released by Genor Biopharma Holdings Limited (6998) in 2021, sourced directly from the official regulator.

62 Filings

2021 Period

2021 filings (62)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT - APPOINTMENT OF MEMBERS OF SCIENTIFIC ADVISORY BOARD Board/Management Information	2021-12-28	English
CHANGE OF COMPANY SECRETARY, AUTHORISED REPRESENTATIVE AND AGENT FOR THE SERVICE OF PROCESS IN HONG KONG Board/Management Information	2021-12-22	English
VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL APPLICATION TO THE BELLBERRY HREC ETHICS COMMITTEE FOR FIRST-IN-HUMAN CLINICAL TRIAL OF GB263T Regulatory Filings	2021-12-22	English
Next Day Disclosure Return Share Issue/Capital Change	2021-12-21	English
Next Day Disclosure Return Share Issue/Capital Change	2021-12-20	English
Next Day Disclosure Return Share Issue/Capital Change	2021-12-14	English
Next Day Disclosure Return Share Issue/Capital Change	2021-12-07	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2021 Share Issue/Capital Change	2021-12-06	English
Next Day Disclosure Return Share Issue/Capital Change	2021-11-16	English
Next Day Disclosure Return Share Issue/Capital Change	2021-11-15	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2021 Regulatory Filings	2021-11-04	English
Next Day Disclosure Return Share Issue/Capital Change	2021-11-03	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2021-11-02	English
ANNOUNCEMENT - (1) CHANGE OF CHAIRMAN AND NON-EXECUTIVE DIRECTOR; AND (2) CHANGE IN COMPOSITION OF BOARD COMMITTEE Board/Management Information	2021-11-02	English
Next Day Disclosure Return Share Issue/Capital Change	2021-10-29	English
Next Day Disclosure Return Share Issue/Capital Change	2021-10-15	English
Next Day Disclosure Return Share Issue/Capital Change	2021-10-11	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2021 Regulatory Filings	2021-10-07	English
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT ENROLLED IN THE PHASE III CLINICAL TRIAL OF GB491 IN CHINA Regulatory Filings	2021-09-28	English
Notification Letter and Request Form to Non-registered Holders Report Publication Announcement	2021-09-27	English
Notification Letter and Change Request Form to Registered Holders Report Publication Announcement	2021-09-27	English
2021 Interim Report Interim / Quarterly Report H1 2021	2021-09-27	English
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN THE PHASE I/IIA CLINICAL TRIAL OF GB492 IN CHINA Regulatory Filings	2021-09-16	English
CHANGE OF COMPANY NAME AND CHANGE OF STOCK SHORT NAME Board/Management Information	2021-09-15	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2021 Regulatory Filings	2021-09-06	English
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT ENROLLED IN THE FIH CLINICAL TRIAL OF GB261 IN AUSTRALIA Regulatory Filings	2021-09-01	English
GRANT OF SHARE OPTIONS Share Issue/Capital Change	2021-08-27	English
PROPOSED ISSUE OF NEW SHARES UNDER THE 2021 RSU PLAN PURSUANT TO GENERAL MANDATE Capital/Financing Update	2021-08-27	English
Next Day Disclosure Return Share Issue/Capital Change	2021-08-27	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2021 Interim / Quarterly Report H1 2021	2021-08-26	English
ANNOUNCEMENT - APPOINTMENT OF NEW CHIEF BUSINESS OFFICER Board/Management Information	2021-08-17	English
DATE OF BOARD MEETING Report Publication Announcement	2021-08-13	English
Reply Form Regulatory Filings	2021-08-06	English
Letter to Shareholders - Election of Means of Receipt and Language of Corporate Communications Regulatory Filings	2021-08-06	English
ELECTION OF MEANS OF RECEIPT AND LANGUAGE OF CORPORATE COMMUNICATIONS Regulatory Filings	2021-08-06	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2021 Regulatory Filings	2021-08-05	English
2020 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT Regulatory Filings	2021-07-26	English
VOLUNTARY ANNOUNCEMENT - NATIONAL MEDICAL PRODUCTS ADMINISTRATION APPROVES INVESTIGATIONAL NEW DRUG APPLICATION FOR TWO PHASE III CLINICAL STUDIES OF GB491 (LEROCICLIB) Regulatory Filings	2021-07-20	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2021 Share Issue/Capital Change	2021-07-07	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 11 JUNE 2021 AND UPDATE ON THE PROPOSED CHANGE OF COMPANY NAME Declaration of Voting Results & Voting Rights Announcements	2021-06-11	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2021 Share Issue/Capital Change	2021-06-04	English
GRANT OF SHARE OPTIONS Share Issue/Capital Change	2021-06-03	English
(1) ADOPTION OF THE 2021 RSU PLAN AND (2) PROPOSED ISSUE OF NEW SHARES UNDER THE 2021 RSU PLAN PURSUANT TO GENERAL MANDATE Capital/Financing Update	2021-06-03	English
VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL NEW DRUG APPROVAL FOR GB492 BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2021-05-20	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2021 Share Issue/Capital Change	2021-05-06	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD AT 9F, BUILDING 7, LANE 88, SHENGRONG ROAD, PUDONG NEW DISTRICT, SHANGHAI, CHINA ON FRIDAY, 11 JUNE 2021 AT 10:00 A.M. AGM Information	2021-04-27	English
(1) PROPOSED RE-ELECTION OF DIRECTORS; (2) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES; (3) PROPOSED CHANGE OF COMPANY NAME; (4) PROPOSED RE-APPOINTME Proxy Solicitation & Information Statement	2021-04-27	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2021-04-27	English
2020 ANNUAL REPORT Annual Report FY 2020	2021-04-27	English
SUPPLEMENTAL ANNOUNCEMENT ON CHANGE OF NON-EXECUTIVE DIRECTOR AND AUDIT COMMITTEE MEMBER Board/Management Information	2021-04-26	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2021-04-23	English
CHANGE OF NON-EXECUTIVE DIRECTOR AND AUDIT COMMITTEE MEMBER Board/Management Information	2021-04-23	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2021 Share Issue/Capital Change	2021-04-09	English
ANNOUNCEMENT - PROPOSED CHANGE OF COMPANY NAME Board/Management Information	2021-03-23	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2020 Annual Report FY 2020	2021-03-23	English
VOLUNTARY ANNOUNCEMENT - SUBMISSION OF APPLICATION FOR FIRST IN HUMAN CLINICAL TRIAL OF GB261 TO BELLBERRY HUMAN RESEARCH ETHICS COMMITTEE IN AUSTRALIA Regulatory Filings	2021-03-17	English
DATE OF BOARD MEETING Report Publication Announcement	2021-03-11	English
VOLUNTARY ANNOUNCEMENT - NATIONAL MEDICAL PRODUCTS ADMINISTRATION APPROVES INVESTIGATIONAL NEW DRUG APPLICATION FOR TWO GB491 (LEROCICLIB) BRIDGING STUDIES Regulatory Filings	2021-03-08	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 28 February 2021 Share Issue/Capital Change	2021-03-03	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2021 Share Issue/Capital Change	2021-02-03	English
ANNOUNCEMENT - APPOINTMENT OF NEW CHIEF SCIENTIST Board/Management Information	2021-01-29	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2020 Share Issue/Capital Change	2021-01-05	English